J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 31.81 CNY 1.4% Market Closed
Market Cap: 25.7B CNY
Have any thoughts about
Jafron Biomedical Co Ltd?
Write Note

Gross Margin
Jafron Biomedical Co Ltd

78.5%
Current
81%
Average
47.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
78.5%
=
Gross Profit
1.9B
/
Revenue
2.4B

Gross Margin Across Competitors

Country CN
Market Cap 25.7B CNY
Gross Margin
78%
Country US
Market Cap 204.7B USD
Gross Margin
56%
Country US
Market Cap 180.7B USD
Gross Margin
67%
Country US
Market Cap 139.9B USD
Gross Margin
64%
Country US
Market Cap 124.8B USD
Gross Margin
69%
Country IE
Market Cap 114.5B USD
Gross Margin
66%
Country US
Market Cap 67.7B USD
Gross Margin
45%
Country DE
Market Cap 53.6B EUR
Gross Margin
38%
Country CN
Market Cap 338.5B CNY
Gross Margin
65%
Country US
Market Cap 40B USD
Gross Margin
79%
Country US
Market Cap 39.7B USD
Gross Margin
41%

Profitability Report

View the profitability report to see the full profitability analysis for Jafron Biomedical Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
78.5%
=
Gross Profit
1.9B
/
Revenue
2.4B
What is the Gross Margin of Jafron Biomedical Co Ltd?

Based on Jafron Biomedical Co Ltd's most recent financial statements, the company has Gross Margin of 78.5%.